
GSK to Inject ‘Tens of Billions’ in US Amid Trump’s Tariffs, Pipeline Reshuffles
GSK will make a multi-billion-dollar investment in the U.S. in the coming years as the Trump administration’s tariffs materialize. “The U.S. is our number one priority market,” CEO Emma Walmsley told reporters on a media call Wednesday morning, while …